Navigation Links
The Ross Summit to focus on new survival data, technique refinement and availability

ATLANTA, GA (October 12, 2010) More than 100 cardiovascular surgeons and cardiologists from 25 countries are scheduled to attend the third annual global Ross Summit, a two-day surgical congress focused on the Ross Procedure. Filled with a number of point-counterpoint discussions, the forum will feature the presentation of much new data about the Ross Procedure and interactive discussions among many of the world's elite cardiovascular surgeons and cardiologists regarding survival, quality of life, technique refinement and availability of the procedure to the patients who best benefit from it.

CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, will convene the summit at its corporate headquarters training facility in suburban Atlanta Oct. 15 and 16.

"Currently, the Ross Procedure is performed on about 1,500 individuals globally each year. Perhaps the most important advantage of the procedure is growing evidence of improved long-term survival and quality of life over other valve replacement options," said Dr. William Northrup III, vice president of physician relations and education at CryoLife. "The procedure is also attractive because patients who undergo the procedure do not have to take long-term anticoagulant medications after surgery and experience no restrictions in physical activity. Historically, there has been much discussion regarding the survival data and the impact of patient selection on the data. The Ross Summit always provides a balanced opportunity for interactive discussion after each presentation. Of particular interest this year will be presentations and discussions surrounding data for patients into the second decade following their Ross Procedure."

Pioneered in 1967, the Ross Procedure is a type of specialized aortic valve surgery in which the patient's diseased aortic valve is replaced with his or her own pulmonary valve. The pulmonary valve is then typically replaced with a cryopreserved human pulmonary valve. The procedure is a complex surgical technique that is usually performed in specialized centers by surgeons who have developed specific expertise with the procedure. As a result, one of the Summit's sessions will focus on increasing the availability of the procedure to the patients for whom it is best suited by increasing awareness in the cardiologist community and by mentoring the next generation of Ross surgeons.

Led by Professor Sir Magdi Yacoub, FRS, FRCS, of Imperial College's Heart Science Center in London in tandem with Dr. Northrup, The Ross Summit also includes two afternoons of hands-on mentored instruction in the various techniques of this specific form of cardiac reconstruction utilizing biological simulators. A full faculty list and summit agenda can be found at

"Things are constantly changing, evolving and improving within the Ross Procedure community," noted Steven G. Anderson, chairman, president and CEO of CryoLife. "It's why CryoLife hosts the Ross Summit annually. The interaction and perspective from peers and the continued sharing of new data have proven valuable to this elite group of cardiothoracic surgeons as evidenced by the repeat registrations each year."

A decellularized human pulmonary heart valve, CryoValve SG, processed using CryoLife's SynerGraft technology, was cleared by the FDA in February 2008 for use in cardiac reconstruction procedures such as the Ross Procedure.


Contact: Dana Hartline
Edelman PR

Related medicine news :

1. Mayo Clinic Sports Medicine to host concussion summit
2. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
3. UN Summit launches drive to save lives of more than 16 million women and children
4. 2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members
5. Cambridge Healthtech Institute Announces its Second Annual "The Bioprocessing Summit"
6. IAS urges donors to maintain commitment to global HIV response ahead of the G8 Summit
7. Summit Credit Union Delivers Random Acts of Kindness; Introducing the DoMore Team
8. MedStar Hospitals Honored at Obstetric Care Conference: The Third Annual PeriGen Knowledge Summit
9. Summit Health, U.S. Preventive Medicine Agree to Continue Worksite Screening Partnership
10. Lenox Hill Hospital Honored at Obstetric Care Conference: The Third Annual PeriGen Knowledge Summit
11. SIUE Pain Summit Recommendations Announced Today
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: